High Purity Cagrilintide China Suppliers Pharmaceutical Factory for Weight Loss Peptides
Premium Cagrilintide and Semaglutide combinations available from leading China suppliers. Our factory provides clinical grade 2.5mg+2.5mg (5MG) and 5mg+5mg (10MG) doses for metabolic research and obesity treatment.
About this product
Product information from the supplier.
Cagrilintide is a sophisticated, long-acting acylated amylin analogue engineered for high potency in metabolic regulation. By precisely targeting amylin receptors (AMYR) and calcitonin G protein-coupled receptors (CTR), it delivers a powerful mechanism for appetite suppression and weight management, positioning it as a frontier compound in the treatment of clinical obesity.
Extensive in vivo studies have validated Cagrilintide's superior efficacy in significantly reducing food intake with sustained therapeutic effects over multiple days. Currently utilized in rigorous clinical settings, this compound is pivotal in exploring advanced synergistic strategies to address chronic obesity and associated metabolic dysfunctions.
Detailed Parameters
| Product Name | Cagrilintide + Semaglutide | Compound Type | Acylated Amylin Analogue / GLP-1 RA |
|---|---|---|---|
| Target Receptors | AMYR & CTR | Primary Application | Obesity & Metabolic Treatment |
| Action Mechanism | Appetite Suppression | Effect Duration | Long-acting / Sustained |
| Research Stage | Clinical Exploration | Biological Activity | High Potency |
| Category | Peptide / Bio-pharmaceutical | Molecular Origin | Genetic Engineering |
Key Advantages
High Receptor Affinity
Precision targeting of AMYR and CTR receptors ensures maximum biological efficacy.
Extended Half-Life
Acylated structure allows for long-acting effects, reducing dosing frequency.
Significant Weight Loss
Demonstrated capability to induce substantial weight reduction in clinical models.
Potent Satiety Control
Effectively reduces caloric intake by modulating food craving signals.
Metabolic Synergy
Optimized for use alongside other peptides to enhance glucose regulation.
Clinical Grade Purity
Manufactured under strict genetic engineering and peptide synthesis standards.
Product Gallery
Management Platforms
Cold Chain Logistics
Ensuring peptide stability through precise temperature-controlled shipping.
Synthesis Precision
Advanced automated peptide synthesis for consistent molecular weight.
Quality Monitoring
Real-time purity analysis using high-performance liquid chromatography.
Batch Traceability
Comprehensive tracking from raw amino acids to final vial distribution.
Inventory Control
Smart storage management to optimize shelf-life and availability.
Regulatory Compliance
Adherence to global pharmaceutical manufacturing and safety guidelines.
Investment Return Comparison
| Metric | Standard Peptides | Cagrilintide Complex |
|---|---|---|
| Efficacy Rate | Moderate | Exceptional |
| Duration of Action | Short/Medium | Long-acting |
| Patient Compliance | Low (Frequent Dosing) | High (Reduced Dosing) |
| Metabolic Impact | Single Path | Multi-Receptor Target |
| Market Potential | Saturated | High-Growth Frontier |
Frequently Asked Questions
Cagrilintide is a long-acting amylin analogue that targets AMYR and CTR receptors to reduce food intake and promote weight loss in obesity treatment.
While GLP-1s focus on insulin and satiety, Cagrilintide specifically targets the amylin pathway, providing a complementary mechanism for weight reduction.
Yes, it is a prime example of advanced peptide engineering and is widely used in biological pharmaceutical research for metabolic disorders.
To maintain stability and potency, these compounds typically require strictly controlled cold chain storage, often at -20°C or 2-8°C.
Acylation increases the molecule's affinity for albumin, slowing its renal clearance and extending its therapeutic window in the body.
Purity is verified through HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry to ensure the exact molecular sequence.